Bariatric surgery significantly more effective than GLP-1 drugs for weight loss and disease remission, review finds

Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and most comprehensive real-world comparisons of the two treatments. The findings were presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting (ASMBS2026).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup